[ad_1]
Graham Thornicroft
WHO has released evidence-based guidelines for managing physical conditions in adults with severe mental disorders, according to a press release.
The guidelines include recommendations for healthy lifestyle behaviors (eg, healthier diet, more physical activity and tobacco cessation), psychosocial support and
"The majority of people [severe mental disorders] are non-communicable and communicable, " Graham Thornicroft, PhD, FRCPsych, Chairman of the guideline developmental group and Professor of Community Psychiatry at King's College London, and colleagues wrote in the WHO executive summary.
"Equitable access to comprehensive health services remains of [severe mental disorders], "They continued. "Unfortunately, people with [severe mental disorders] often lack access to health services, including promotion and prevention, screening and treatment. It is crucial to address the disparities in health care [severe mental disorders]. "
Cardiovascular disease, diabetes, HIV / AIDS, tuberculosis, hepatitis B and C, tobacco dependence, substance use dependence and / or overweight / obesity. These methods are used to reduce the risk of serious illness and reduce the risk of serious illness.
The WHO guidelines for healthy lifestyle behaviors for people with severe mental illness.
Source: Shutterstock.com
Taking into consideration the potential for interactions between psychotropic and antipsychotic medications and medications for other conditions is a significant feature of the guidelines.
For patients at risk of becoming overweight or obese, WHO recommends initiating a psychotropic medication with lower propensity for weight gain after considering clinical benefits / possible adverse effects. For people with severe mental disorders and pre-existing cardiovascular disease or cardiovascular risk factors, WHO advises initiating a psychotropic medication with lower proclivity for cardiovascular risk.
For those with severe mental disorders and diabetes, clinicians should consider initiating an antipsychotic medication with lower propensity for producing hyperglycemia and be aware of potential interactions. WHO also advises monitoring glycemic control and adjusting dose as needed.
For infectious diseases, clinicians should consider the potential for drug-drug interactions between psychotropic medicines and antiretroviral drugs, tuberculosis medicines and medicines for hepatitis, and C. for tobacco cessation programs, which suggests potential interactions between bupropion and varenicline with psychotropic medications.
"Following the principle of non-discrimination and universal health coverage of the United Nations Sustainable Development Goals, people with [severe mental disorders] The WHO guideline developmental group should be offered at least as much as the general population. – by Savannah Demko
References:
WHO. Management of physical health conditions in adults with severe mental disorders. http://apps.who.int/iris/bitstream/handle/10665/275718/9789241550383-eng.pdf?ua=1. Accessed on Nov. 7, 2018.
$j(window).load(function(){ !function(f,b,e,v,n,t,s) {if(f.fbq)return;n=f.fbq=function(){n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}; if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0'; n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0]; s.parentNode.insertBefore(t,s)}(window,document,'script', 'https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '472649976441888'); fbq('track', 'PageView'); });
[ad_2]
Source link